Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
News Corp Class A
NWSA
$16.7B
| $12.2M | 0.02% |
1,077,137
+383,270
| +55% | +$4.91M |
|
|
WCC
1002
WESCO International
WCC
$16.5B
| $12.2M | 0.02% |
254,434
+106,767
| +72% | +$5.54M |
|
1003
Casey's General Stores
CASY
$30.5B
| $12.2M | 0.02% |
95,188
+92,286
| +3,180% | +$11.7M |
|
1004
Spotify
SPOT
$114B
| $12.2M | 0.02% |
107,458
-24,542
| -19% | -$3.43M |
|
1005
Mercer International
MERC
$28.6M
| $12.2M | 0.02% |
1,165,035
+239,405
| +26% | +$3.33M |
|
1006
Avis
CAR
$5.13B
| $12.2M | 0.02% |
540,938
+421,653
| +353% | +$12.2M |
|
1007
Old Republic International
ORI
$10.2B
| $12.2M | 0.02% |
591,083
+306,643
| +108% | +$6.57M |
|
|
SWI
1008
DELISTED
SolarWinds Corporation Common Stock
SWI
| $12.1M | 0.02% |
+831,266
| New | +$13M |
|
|
AXNX
1009
DELISTED
Axonics, Inc. Common Stock
AXNX
| $12.1M | 0.02% |
+798,950
| New | +$11.9M |
|
|
ADAP
1010
DELISTED
Adaptimmune Therapeutics
ADAP
| $12.1M | 0.02% |
2,098,272
-74,376
| -3% | -$549K |
|
1011
Integra LifeSciences
IART
$1.31B
| $12M | 0.02% |
267,097
-139,701
| -34% | -$7.66M |
|
|
INXN
1012
DELISTED
Interxion Holding N.V.
INXN
| $12M | 0.02% |
222,217
-319,276
| -59% | -$19.2M |
|
1013
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
| $12M | 0.02% |
51,473
+23,781
| +86% | +$5.93M |
|
1014
Amalgamated Financial
AMAL
$1.45B
| $12M | 0.02% |
614,528
-182,570
| -23% | -$3.58M |
|
1015
Huntington Bancshares
HBAN
$34.2B
| $12M | 0.02% |
1,003,146
+769,766
| +330% | +$10.7M |
|
|
RSX
1016
CALL
DELISTED
VanEck Russia ETF
RSX
| $11.9M | 0.02% |
636,600
+611,300
| +2,416% | +$12.6M |
|
|
ETRN
1017
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $11.9M | 0.02% |
+595,200
| New | +$12.6M |
|
|
SEM
1018
DELISTED
Select Medical
SEM
| $11.9M | 0.02% |
1,438,315
+324,672
| +29% | +$3.11M |
|
|
ACOR
1019
DELISTED
Acorda Therapeutics
ACOR
| $11.9M | 0.02% |
6,361
-38
| -0.6% | -$82.7K |
|
1020
iShares MSCI Thailand ETF
THD
$355M
| $11.8M | 0.02% |
142,923
+112,400
| +368% | +$9.75M |
|
|
B
1021
DELISTED
Barnes Group Inc.
B
| $11.8M | 0.02% |
219,745
+147,950
| +206% | +$8.69M |
|
1022
Best Buy
BBY
$18B
| $11.8M | 0.02% |
+222,267
| New | +$14.5M |
|
1023
HUB Group
HUBG
$2.4B
| $11.8M | 0.02% |
634,524
-450,778
| -42% | -$9.67M |
|
1024
PUT
SLB Ltd
SLB
$79.1B
| $11.8M | 0.02% |
325,700
+125,700
| +63% | +$6.2M |
|
|
VRN
1025
DELISTED
Veren
VRN
| $11.7M | 0.02% |
3,885,613
+2,997,792
| +338% | +$12.8M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.